Association between G2385R and R1628P polymorphism of LRRK2 gene and sporadic Parkinson’s disease in a Han-Chinese population in south-eastern China

被引:0
作者
Jiangping Cai
Yi Lin
Wanjin Chen
Qifang Lin
Bin Cai
Ning Wang
Weihong Zheng
机构
[1] First Affiliated Hospital,Department of Neurology and Institute of Neurology, Center of Neuroscience
[2] Fujian Medical University,Department of Neurology
[3] First Affiliated Hospital of Quanzhou,Department of Neurology
[4] Fujian Medical University,undefined
[5] Zhongshan Hospital,undefined
[6] Xiamen University,undefined
来源
Neurological Sciences | 2013年 / 34卷
关键词
Parkinson’s disease; LRRK2; G2385R; R1628P; Chinese;
D O I
暂无
中图分类号
学科分类号
摘要
The G2385R and R1628P polymorphisms of the leucine-rich repeat kinase 2 (LRRK2) gene have been reported to be associated with Parkinson’s disease (PD), but no data are available on Han-Chinese population of south-eastern China. This study aimed to investigate whether G2385R and R1628P variants are associated with sporadic PD in this population. Total 1,060 subjects were enrolled; including 550 unrelated healthy controls and 510 patients with sporadic PD. Genotyping of polymorphisms was performed by PCR–restriction fragment length polymorphism analysis. All variant samples were sequenced for further confirmation. The results showed that the A allele of the G2385R variant was significantly enriched in sporadic PD patient group (4.8 %) when compared with control group [1.1 %; odds ratio (OR) 4.58, 95 % confidence interval (CI) 2.42–8.65, P < 0.01]. However, no significant difference in the frequency of the C allele of R1628P polymorphism variant was observed between cases and controls (2.8 vs. 1.7 %, OR 1.67, 95 % CI 0.93–2.99, P = 0.08). In conclusion, this study provides the first evidence that G2385R polymorphism is a risk factor for sporadic PD in Han-Chinese population of south-eastern China.
引用
收藏
页码:2001 / 2006
页数:5
相关论文
共 82 条
[1]  
Dachsel JC(2010)Lrrk2 and Parkinson disease Arch Neurol 67 542-547
[2]  
Farrer MJ(2006)Lrrk2 in Parkinson’s disease: protein domains and functional insights Trends Neurosci 29 286-293
[3]  
Mata IF(2009)Parkin protects against lrrk2 G2019S mutant-induced dopaminergic neurodegeneration in drosophila J Neurosci 29 11257-11262
[4]  
Wedemeyer WJ(2008)Intramolecular activation mechanism of the dictyostelium lrrk2 homolog roco protein gbpc J Biol Chem 283 30412-30420
[5]  
Farrer MJ(2008)Lrrk2 R1628P increases risk of Parkinson’s disease: replication evidence Hum Genet 124 287-288
[6]  
Taylor JP(2006)Lrrk2 G2019S as a cause of Parkinson’s disease in North African Arabs N Engl J Med 354 422-423
[7]  
Gallo KA(2006)Lrrk2 G2019S as a cause of Parkinson’s disease in Ashkenazi Jews N Engl J Med 354 424-425
[8]  
Ng CH(2011)A study of six point mutation analysis of LRRK2 gene in Chinese mainland patients with Parkinson’s disease Neurol Sci 32 741-742
[9]  
Mok SZ(2007)The lrrk2 Gly2385Arg variant is associated with Parkinson’s disease: genetic and functional evidence Hum Genet 120 857-863
[10]  
Koh C(2008)Analysis of lrrk2 R1628P as a risk factor for Parkinson’s disease Ann Neurol 64 88-92